e-Bulletin August 2025
IN THE MEDIA |
Automated Organoid Platform Debuts at C2i
Breakthrough in Translational Research
The Centre for Immunology & Infection (C2i) has achieved a significant scientific milestone with the introduction of Hong Kong and Greater China’s first automated organoid culture machine, developed in collaboration with Hitachi East Asia Limited. This new automated organoid production will expand the use in drug testing, infection studies, and potentially transplants, making treatments safer and more personalised.
Professor Michael Chan, Professor of our School and Lead Scientist of C2i, along with his team, is collaborating with HKU Department of Medicine and Department of Paediatrics and Adolescent Medicine to conduct drug screening for 50 to 100 asthma patients, aiming to identify precise and timely treatments. Professor Chan also plans to extend this innovative approach to benefit lung cancer patients, predicting potential side effects in advance to avoid risky trial medications and optimise treatment timelines.
To read the news, please click the following links to Mingpao (Chinese) and South China Morning Post (English).
